Modulation of insulin action
- 13 January 2004
- journal article
- review article
- Published by Springer Nature in Diabetologia
- Vol. 47 (2) , 170-184
- https://doi.org/10.1007/s00125-003-1313-3
Abstract
Insulin is a key hormone regulating the control of metabolism and the maintenance of normoglycaemia and normolipidaemia. Insulin acts by binding to its cell surface receptor, thus activating the receptor’s intrinsic tyrosine kinase activity, resulting in receptor autophosphorylation and phosphorylation of several substrates. Tyrosine phosphorylated residues on the receptor itself and on subsequently bound receptor substrates provide docking sites for downstream signalling molecules, including adapters, protein serine/threonine kinases, phosphoinositide kinases and exchange factors. Collectively, those molecules orchestrate the numerous insulin-mediated physiological responses. A clear picture is emerging of the way in which insulin elicits several intracellular signalling pathways to mediate its physiologic functions. A further challenge, being pursued by several laboratories, is to understand the molecular mechanisms that underlie insulin action at the peripheral level, deregulation of which ultimately leads to hyperglycaemia and Type 2 diabetes. We review how circulating factors such as insulin itself, TNF-α, interleukins, fatty acids and glycation products influence insulin action through insulin signalling molecules themselves or through other pathways ultimately impinging on the insulin-signalling pathway. Understanding how the mechanism by which molecular insulin action is modulated by these factors will potentially provide new targets for pharmacological agents, to enable the control of altered glucose and lipid metabolism and diabetes.Keywords
This publication has 95 references indexed in Scilit:
- Transactivation of ErbB2 and ErbB3 by Tumor Necrosis Factor-α and Anisomycin Leads to Impaired Insulin Signaling through Serine/Threonine Phosphorylation of IRS ProteinsPublished by Elsevier ,2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Prevention of fat-induced insulin resistance by salicylateJournal of Clinical Investigation, 2001
- Insulin Induction of SOCS-2 and SOCS-3 mRNA Expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5*Journal of Biological Chemistry, 2001
- Suppressor of Cytokine Signaling (SOCS)-3 Protein Interacts with the Insulin-like Growth Factor-I ReceptorBiochemical and Biophysical Research Communications, 2000
- Hyperglycemia Impairs the Insulin Signaling Step between PI 3-Kinase and Akt/PKB Activations in ZDF Rat LiverBiochemical and Biophysical Research Communications, 1999
- A Role for Nuclear Factor κB in the Antiapoptotic Function of InsulinPublished by Elsevier ,1998
- 14-3-3β Protein Associates with Insulin Receptor Substrate 1 and Decreases Insulin-stimulated Phosphatidylinositol 3′-Kinase Activity in 3T3L1 AdipocytesPublished by Elsevier ,1998
- Insulin Stimulates the Degradation of IRS-1 in 3T3-L1 AdipocytesBiochemical and Biophysical Research Communications, 1993
- Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.Journal of Clinical Investigation, 1987